ARCHIVES

New Immunotherapy Increased Survival Of Neuroblastoma In Phase III Trial

This article is from The Cancer Letter archive.

Vol. 33 No. 9 | September 24, 2010

Download PDF Visit The Full Archive

Related Articles

Abraxane Improves Progression-Free Survival Compared to Decarbazine In Stage IV Disease

November 30, 2012

Funding Opportunities: NCI Grant Supplements For Mammalian Models

October 22, 1999

Medenica’s Privileges Extended; Patient sue Hilton Head Physicians

June 4, 1993

Henderson Committee Final Recommendation Made On P01s

February 10, 1984

NCI Intramural Research: More Than 200 Scientists At Frederick To Become NCI Employees This Year

March 26, 1999

Almost Half of Faculty on IRBs Have Industry Ties, Study Finds

September 26, 2003